<i>In vivo</i> comparison of the relative systemic bioavailability of fluticasone propionate from three anti‐static spacers and a metered dose inhaler

Abstract

All three antistatic spacers significantly increased the relative systemic bioavailability of HFA-FP compared with the standard pMDI. --EudraCT Database trial registration number: 2005-005557-22.